reports Hepatitis C High cost of hepatitis drug reflects a broken pricing system High cost of hepatitis drug reflects a broken pricing system High cost of hepatitis drug reflects a broken pricing system High cost of hepatitis drug reflects a broken pricing system High cost of hepatitis drug reflects a broken pricing system High cost of hepatitis drug reflects a broken pricing system High cost of hepatitis drug reflects a broken pricing system The Los Angeles Times $100,000 for only a few weeks Gilead Sciences caused a huge stir outright refuse